Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin

European Journal of Pharmaceutical Sciences

Volumn 46, Issue 3, 2012, Pages 131-141

  Wei, Minyan ^a   Xu, Yuehong ^a   Zou, Qi ^a   Tu, Liuxiao ^a   Tang, Chenyi ^a   Xu, Ting ^a   Deng, Lihe ^a   Wu, Chuanbin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Asialoglycoprotein receptor; Hepatocellular carcinoma; Lactoferrin; PEGylated liposomes; Post insertion; Targeting delivery

Indexed keywords

AMIDE; COUMARIN; COUMARIN 6; FLUORESCENT DYE; IMMUNOLIPOSOME; LACTOFERRIN; LIPID; LIPOSOME; MACROGOL 2000; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEPG2; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENCAPSULATION; FILM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDRATION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; COUMARINS; HEP G2 CELLS; HUMANS; LACTOFERRIN; LIPOSOMES; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NIH 3T3 CELLS; POLYETHYLENE GLYCOLS; RANDOM ALLOCATION; THIAZOLES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84862779216     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.02.007     Document Type: Article

References (69)

1. A. Abu-Lila, T. Suzuki, Y. Doi, T. Ishida, and H. Kiwada Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model J. Control. Release 134 2009 18 25
2. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822 (Pubitemid 38374867)
3. S. Anabousi, M. Laue, C.M. Lehr, U. Bakowsky, and C. Ehrhardt Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy Eur. J. Pharm. Biopharm. 60 2005 295 303 (Pubitemid 40804569)
4. S. Anabousi, U. Bakowsky, M. Schneider, H. Huwer, C.M. Lehr, and C. Ehrhardt In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer Eur. J. Pharm. Sci. 29 2006 367 374 (Pubitemid 44709858)
5. T.L. Andresen, S.S. Jensen, and K. Jørgensen Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release Prog. Lipid Res. 44 2005 68 97 (Pubitemid 40313220)
6. S. Bai, V. Gupta, and F. Ahsan Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study Eur. J. Pharm. Sci. 38 2009 165 171
7. E.N. Baker Lactoferrin: a multi-tasking protein par excellence Cell Mol. Life Sci. 62 2005 2529 2530 (Pubitemid 41721227)
8. D.J. Bennatt, and D.D. McAbee Identification and isolation of a 45-kDa calcium-dependent lactoferrin receptor from rat hepatocytes Biochemistry 36 1997 8359 8366 (Pubitemid 27297547)
9. D.J. Bennatt, Y.Y. Ling, and D.D. McAbee Isolated rat hepatocytes bind lactoferrins by the RHL-1 subunit of the asialoglycoprotein receptor in a galactose independent manner Biochemistry 36 1997 8367 8376 (Pubitemid 27297548)
10. A. Bicho, I.N. Pea, A.C. Roque, and M.M. Cardoso Anti-CD8 conjugated nanoparticles to target mammalian cells expressing CD8 Int. J. Pharm. 399 2010 80 86
11. J.D. Byrne, T. Betancourt, and L. Brannon-Peppas Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Deliv. Rev. 60 2008 1615 1626
12. H. Chen, L. Tang, Y. Qin, Y. Yin, J. Tang, W. Tang, X. Sun, Z. Zhang, J. Liu, and Q. He Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery Eur. J. Pharm. Sci. 40 2010 94 102
13. P. Couvreur, and F. Puisicux Nano- and microparticles for the delivery of polypeptides and proteins Adv. Drug Deliv. Rev. 10 1993 141 162 (Pubitemid 23172580)
14. S.E. Crawford, and J. Borensztajn Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis. Evidence for a lactoferrinsensitive and apolipoprotein e-independent pathway J. Lipid Res. 40 1999 797 805 (Pubitemid 29220520)
15. M. Davboren, E. Herzog, A. Casey, B. Cottineau, G. Chambers, H.J. Byrne, and F.M. Lyng In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells Toxicol. in vitro 21 2007 438 448 (Pubitemid 46453117)
16. T.A. Elbayoumi, and V.P. Torchilin Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines Eur. J. Pharm. Sci. 32 2007 159 168 (Pubitemid 47532709)
17. T.J. Evjen, E. Hagtvet, E.A. Nilssen, M. Brandl, and S.L. Fossheim Sonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicin Eur. J. Pharm. Sci. 43 2011 318 324
18. L. Fiume, and G. Di Stefano Lactosaminated human albumin, a hepatotropic carrier of drugs Eur. J. Pharm. Sci. 40 2010 253 262
19. A. Gabizon, H. Shmeeda, A.T. Horowitz, and S. Zalipsky Tumor cell targeting of liposme-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates Adv. Drug Deliv. Rev. 56 2004 1177 1192 (Pubitemid 38496514)
20. J. Gao, W. Zhong, J. He, H. Li, H. Zhang, G. Zhou, B. Li, Y. Lu, H. Zou, G. Kou, D. Zhang, H. Wang, Y. Guo, and Y. Zhong Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes Int. J. Pharm. 374 2009 145 152
21. S.A. Guhagarkar, R.V. Gaikwad, A. Samad, V.C. Malshe, and P.V. Devarajan Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting Int. J. Pharm. 401 2010 113 122
22. R. Huang, W. Ke, Y. Liu, C. Jiang, and Y. Pei The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain Biomaterials 29 2008 238 246 (Pubitemid 350016299)
23. K. Hu, J. Li, Y. Shen, W. Lu, X. Gao, Q. Zhang, and X. Jiang Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations J. Control. Release 134 2009 55 61
24. D.L. Iden, and T.M. Allen In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach Biochim. Biophys. Acta. 1513 2001 207 216 (Pubitemid 32706418)
25. T. Ishida, D.L. Iden, and T.M. Allen A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs FEBS Lett. 460 1999 129 133 (Pubitemid 29479257)
26. Y. Iwamaru, Y. Shimizu, M. Imamura, Y. Murayama, R. Endo, Y. Tagawa, Y. Ushiki-Kaku, T. Takenouchi, H. Kitani, S. Mohri, T. Yokoyama, and H. Okada Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation J. Neurochem. 107 2008 636 646
27. A. Jain, and S.K. Jain In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors Eur. J. Pharm. Sci. 35 2008 404 416
28. C. Kirchner, T. Liedl, S. Kudera, T. Pellegrino, A.M. Javier, H.E. Gaub, S. Stolzle, N. Fertig, and W.J. Parak Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles Nano Lett. 5 2005 331 338 (Pubitemid 40308295)
29. S.D. Li, S. Chono, and L. Huang Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles J. Control. Release 126 2008 77 84
30. S.D. Li, and L. Huang Nanoparticles evading the reticuloendothelial system: role of the supported bilayer Biochim. Biophys. Acta. 1788 2009 2259 2266
31. X. Li, L. Ding, Y. Xu, Y. Wang, and Q. Ping Targeted delivery of doxorubicin using stealth liposomes modified with transferrin Int. J. Pharm. 373 2009 116 123
32. C.L. Li, J.X. Cui, C.X. Wang, L. Zhang, Y.H. Li, L. Zhang, X. Xiu, Y.F. Li, and N. Wei Development of pegylated liposomal vinorelbine formulation using "post-insertion" technology Int. J. Pharm. 391 2010 230 236
33. M. Loi, S. Marchi, P. Becherini, D. Di Paolo, M. Soster, F. Curnis, C. Brignole, G. Pagnan, P. Perri, I. Caffa, R. Longhi, B. Nico, F. Bussolino, C. Gambini, D. Ribatti, M. Cilli, W. Arap, R. Pasqualini, T.M. Allen, A. Corti, M. Ponzoni, and F. Pastorino Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma J. Control. Release 145 2010 66 73
34. N. Maeda, Y. Takeuchi, M. Takada, Y. Sadzuka, Y. Namba, and N. Oku Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome J. Control. Release 100 2004 41 52 (Pubitemid 39445984)
35. J. Mai, S. Song, M. Rui, D. Liu, Q. Ding, J. Peng, and Y. Xu A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells J. Control. Release 139 2009 174 181
36. K. Maruyama PEG-immunoliposome Biosci. Rep. 22 2002 251 266 (Pubitemid 35222734)
37. D.D. McAbee, and K. Esbensen Binding and endocytosis of apo- and hololactoferrin by isolated rat hepatocytes J. Biol. Chem. 266 1991 23624 23631 (Pubitemid 21908843)
38. D.D. McAbee, D.J. Bennatt, and Y.Y. Ling Identification and analysis of a CA(2+)-dependent lactoferrin receptor in rat liver. Lactoferrin binds to the asialoglycoprotein receptor in a galactose-independent manner Adv. Exp. Med. Biol. 443 1998 113 121 (Pubitemid 28432177)
39. D.D. McAbee, X. Jiang, and K.B. Walsh Lactoferrin binding to the rat asialoglycoprotein receptor requires the receptor's lectin properties Biochem J. 348 2000 113 117 (Pubitemid 30312138)
40. M. Meilinger, M. Haumer, K.A. Szakmary, F. Steinbock, B. Scheiber, H. Goldenberg, and M. Huettinger Removal of lactoferrin from plasma is mediated by binding to low density lipoprotein receptor-related protein alpha(2)- macroglobulin receptor and transport to endosomes FEBS Lett. 360 1995 70 74
41. J.H. Moon, S.B. Kang, J.S. Park, B.W. Lee, E.S. Kang, C.W. Ahn, H.C. Lee, and B.S. Cha Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression Metabolism 60 2011 930 940
42. S.T. Oh, J.K. Rih, H.S. Kwon, D.S. Hwang, S.Y. Kim, and J.B. Yim Lactoferrin as a gene delivery vehicle to hepatocytes Exp. Mol. Med. 29 1997 111 116 (Pubitemid 27323066)
43. P. Opanasopit, M. Sakai, M. Nishikawa, S. Kawakami, F. Yamashita, and M. Hashida Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers J. Control. Release 80 2002 283 294 (Pubitemid 34273766)
44. J.W. Park, D.B. Kirpotin, K. Hong, R. Shalaby, Y. Shao, U.B. Nielsen, J.D. Marks, D. Papahadjopoulos, and C.C. Benz Tumor targeting using anti-her2 immunoliposomes J. Control. Release 74 2001 95 113 (Pubitemid 32727613)
45. J.W. Park, K. Hong, D.B. Kirpotin, G. Colbern, R. Shalaby, J. Baselga, Y. Shao, U.B. Nielsen, J.D. Marks, D. Moore, D. Papahadjopoulos, and C.C. Benz Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery Clin. Cancer. Res. 8 2002 1172 1181 (Pubitemid 35177372)
46. A. Pathak, S.P. Vyas, and K.C. Gupta Nano-vectors for efficient liver specific gene transfer Int. J. Nanomed. 3 2008 31 49 (Pubitemid 351517074)
47. S.W. Reulen, W.W. Brusselaars, S. Langereis, W.J. Mulder, M. Breuken, and M. Merkx Protein-liposome conjugates using cysteine-lipids and native chemical ligation Bioconjugate Chem. 18 2007 590 596 (Pubitemid 46493534)
48. S. Salmaso, J.S. Pappalardo, R.R. Sawant, T. Musacchio, K. Rockwell, P. Caliceti, and V.P. Torchilin Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers Bioconjug. Chem. 20 2009 2348 2355
49. H.M. Sanders, G.J. Strijkers, W.J. Mulderc, H.P. Huininkd, S.J. Erichd, O.C. Adand, N.A. Sommerdijk, M. Merkxe, and K. Nicolaya Morphology, binding behavior and MR-properties of paramagnetic collagen-binding liposomes Contrast Media Mol. Imaging. 4 2009 81 88
50. R. Savla, O. Taratula, O. Garbuzenko, and T. Minko Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer J. Control. Release 153 2011 16 22
51. P. Simard, and J.C. Leroux PH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells Int. J. Pharm. 381 2009 86 96
52. C.K. Song, S.H. Jung, D.D. Kim, K.S. Jeong, B.C. Shin, and H. Seong Disaccharide-modified liposomes and their in vitro intracellular uptake Int. J. Pharm. 380 2009 161 169
53. D.K. Strickland, S.L. Gonias, and W.S. Argraves Diverse roles for the LDL receptor family Trends Endocrinol Metab. 13 2002 66 74 (Pubitemid 36740449)
54. Y.A. Suzuki, V. Lopez, and B. Lönnerdal Mammalian lactoferrin receptors: structure and function Cell Mol. Life Sci. 62 2005 2560 2575 (Pubitemid 41721230)
55. Z. Thotathil, and M.B. Jameson Early experience with novel immunomodulators for cancer treatment Exper. Opin. Invest. Drugs 16 2007 1391 1403 (Pubitemid 47491409)
56. M.B. Thomas, J.P. O'Beirne, J. Furuse, A.T. Chan, G. Abou-Alfa, and P. Johnson Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy Ann. Surg. Oncol. 15 2008 1008 1014
57. V.P. Torchilin Drug targeting Eur. J. Pharm. Sci. 11 2000 81 91
58. V.P. Torchilin, T.S. Levchenko, R. Rammohan, N. Volodina, B. Papahadjopoulos-Sternberg, and G.G. D'Souza Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes Proc. Natl. Acad. Sci. USA 100 2003 1972 1977 (Pubitemid 36254558)
59. N. Tyagi, and P.C. Ghosh Folate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: Effect of monensin intercalated into folate-tagged liposomes Eur. J. Pharm. Sci. 43 2011 343 353
60. A.S. Ulrich Biophysical aspects of using liposomes as delivery vehicles Biosci. Rep. 22 2002 129 150 (Pubitemid 35222729)
61. P.S. Uster, T.M. Allen, B.E. Daniel, C.J. Mendez, M.S. Newman, and G.Z. Zhu Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time FEBS Lett. 386 1996 243 246 (Pubitemid 26173078)
62. M. Varela, M. Sala, J.M. Llovet, and J. Bruix Treatment of hepatocellular carcinoma: is there an optimal strategy Cancer Treat. Rev. 29 2003 99 104 (Pubitemid 36519391)
63. P.P. Ward, S. Uribe-Luna, and O.M. Conneely Lactoferrin and host defense Biochem. Cell Biol. 80 2002 95 102 (Pubitemid 34194233)
64. Y. Xiang, L. Liang, X. Wang, J. Wang, X. Zhang, and Q. Zhang Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes J. Control. Release 152 2011 402 410
65. H. Xie, Y. Zhu, W. Jiang, Q. Zhou, H. Yang, N. Gu, Y. Zhang, H. Xu, H. Xu, and X. Yang Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo Biomaterials 32 2011 495 502
66. Z. Xu, L. Chen, W. Gu, Y. Gao, L. Lin, Z. Zhang, Y. Xi, and Y. Li The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma Biomaterials 30 2009 226 232
67. Z. Xu, Z. Zhang, Y. Chen, L. Chen, L. Lin, and Y. Li The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model Biomaterials 31 2010 916 922
68. X. Ying, H. Wen, W.L. Lu, J. Du, J. Guo, W. Tian, Y. Men, Y. Zhang, R.J. Li, T.Y. Yang, D.W. Shang, J.N. Lou, L.R. Zhang, and Q. Zhang Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals J. Control. Release 141 2010 183 192
69. W.C. Zamboni Liposomal, nanoparticle, and conjugated formulations of anticancer agents Clin. Cancer Res. 11 2005 8230 8234 (Pubitemid 41746931)